Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides
NCT05526638 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2023-02-02
Summary
Estimation of serum and tissue level of IL-15 and IL-15 R α in mycosis fungoides prior to after treatment.
Conditions
- Mycosis Fungoides
Interventions
- RADIATION
-
ultraviolet phototherapy
thrice weekly sessions of ultraviolet phototherapy
Sponsors & Collaborators
-
Cairo University
lead OTHER
Principal Investigators
-
Randa Youssef, MD · Cairo University
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-01-01
- Primary Completion
- 2023-04-30
- Completion
- 2023-05-30
Countries
- Egypt
Study Locations
More Related Trials
-
Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo
NCT05121532 ·Status: UNKNOWN ·Phase: NA
-
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
NCT04904146 ·Status: RECRUITING
-
Early Diagnosis of Mycosis Fungoides
NCT02539472 ·Status: UNKNOWN ·Phase: NA
-
Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized Scleroderma
NCT02002897 ·Status: UNKNOWN ·Phase: NA
-
Resident Memory T Cells in Vitiligo
NCT05223738 ·Status: UNKNOWN
-
Gene Polymorphism in Tinea Versicolor
NCT04769804 ·Status: UNKNOWN
-
Histochemical Study of Vitiligo in Sohag University Hospital Patients
NCT05869942 ·Status: UNKNOWN ·Phase: NA
-
Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
NCT04892381 ·Status: UNKNOWN
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions
NCT05927272 ·Status: RECRUITING ·Phase: NA
-
Fresolimumab In Systemic Sclerosis
NCT01284322 ·Status: COMPLETED ·Phase: PHASE1
-
Thymic Stromal Lymphopoietin (TSLP) in Vitiligo
NCT03367273 ·Status: COMPLETED ·Phase: NA
-
Epidermal Cell Transplantation in Vitiligo Skin
NCT01629979 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Tissue-resident Memory T Cells Expression Among the Repigmentation Patterns Induced by NB-UVB Phototherapy in Vitiligo
NCT05506995 ·Status: COMPLETED
-
Interest of a Systematic Biopsy for Hard-to-heal Leg Ulcers
NCT00709631 ·Status: COMPLETED
-
Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases
NCT04922736 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin
NCT03423004 ·Status: COMPLETED ·Phase: NA
-
Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis
NCT02339441 ·Status: COMPLETED
-
Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo
NCT05812079 ·Status: NOT_YET_RECRUITING
-
Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis
NCT00628797 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
NCT00368784 ·Status: COMPLETED
-
Janus Kinase 1 in Vitiligo & Psoriasis
NCT03762551 ·Status: COMPLETED ·Phase: NA
-
Dermoscopy in Nails
NCT06696612 ·Status: NOT_YET_RECRUITING
-
Human Beta-defensin 1 in Vitiligo
NCT03832751 ·Status: UNKNOWN ·Phase: NA